524394 Stock Overview
Provides contract research and testing services in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Vimta Labs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹784.00 |
| 52 Week High | ₹804.85 |
| 52 Week Low | ₹390.60 |
| Beta | 0.67 |
| 11 Month Change | 39.28% |
| 3 Month Change | 56.91% |
| 1 Year Change | 86.89% |
| 33 Year Change | 123.14% |
| 5 Year Change | 666.75% |
| Change since IPO | 71,172.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524394 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 5.9% | -3.7% | -3.3% |
| 1Y | 86.9% | 46.7% | 27.5% |
Return vs Industry: 524394 exceeded the Indian Life Sciences industry which returned 46.7% over the past year.
Return vs Market: 524394 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 524394 volatility | |
|---|---|
| 524394 Average Weekly Movement | 8.4% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524394's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524394's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,428 | Harita Vasireddi | vimta.com |
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies.
Vimta Labs Limited Fundamentals Summary
| 524394 fundamental statistics | |
|---|---|
| Market cap | ₹17.38b |
| Earnings (TTM) | ₹493.32m |
| Revenue (TTM) | ₹3.38b |
35.2x
P/E Ratio5.1x
P/S RatioIs 524394 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524394 income statement (TTM) | |
|---|---|
| Revenue | ₹3.38b |
| Cost of Revenue | ₹942.90m |
| Gross Profit | ₹2.43b |
| Other Expenses | ₹1.94b |
| Earnings | ₹493.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 22.25 |
| Gross Margin | 72.07% |
| Net Profit Margin | 14.61% |
| Debt/Equity Ratio | 3.4% |
How did 524394 perform over the long term?
See historical performance and comparison